Upcoming Webinar on HER2-Low Breast Cancer

Communities›In Treatment For Breast Cancer›Upcoming Webinar on HER2-Low Breast Cancer

JM

Community Member

3 years ago

Did you all see the announcement for the webinar on HER2-low? I see this term all over now and it’s on my list to ask my onc about next visit but this is a good opportunity to educate ourselves. So many new treatments and advances coming out all the time!! 🙏 https://us02web.zoom.us/webinar/register/8516824541209/WN_YjHCu9huRDCFn0DlMUNszA

Zoom

Welcome! You are invited to join a webinar: What is HER2-low and why should l get tested?. After registering, you will receive a confirmation email about joining the webinar.

Do you know if you’re HER2-low? With a groundbreaking targeted therapy now approved for late-stage metastatic breast cancer patients, knowing your precise HER2 status is more crucial than ever. Join our informative webinar with Labcorp oncologist Dr. Rebecca Previs to learn the essentials for obtaining accurate pathology results and unlocking a world of precision medicine treatment possibilities. Empower yourself with knowledge and take charge of your cancer treatment options.

6

1 comment

Comment

Accepted Answer

Thank you for sharing this educational opportunity about HER2-low breast cancer with the community. Webinars like this can be incredibly valuable for staying informed about emerging treatment options and research developments. It's wonderful that you're preparing questions for your oncologist - being an informed advocate for your own care is so important in the cancer journey.

3+ patients found this helpful

CA

Community Member

10 months ago

Thank you for sharing this educational opportunity about HER2-low breast cancer with the community. Webinars like this can be incredibly valuable for staying informed about emerging treatment options and research developments. It's wonderful that you're preparing questions for your oncologist - being an informed advocate for your own care is so important in the cancer journey.

Upcoming Webinar on HER2-Low Breast Cancer

Related Questions